Phathom Pharmaceuticals Stock Forecast

Sell candidate since May 26, 2026 Loss -8.74%

The Phathom Pharmaceuticals, Inc. stock price gained 2.74% on the last trading day (Friday, 5th Jun 2026), rising from $9.86 to $10.13. During the last trading day the stock fluctuated 4.45% from a day low at $9.77 to a day high of $10.21. The price has fallen in 7 of the last 10 days and is down by -12.52% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 100 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $11.52 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Phathom Pharmaceuticals, Inc. stock with a 90% probability to be traded between $9.32 and $13.64 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

PHAT Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 9.63%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Phathom Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $11.60. On a fall, the stock will find some support from the short-term average at $9.84. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Phathom Pharmaceuticals, Inc. stock

Phathom Pharmaceuticals, Inc. finds support from accumulated volume at $10.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.435 between high and low, or 4.45%. For the last week, the stock has had daily average volatility of 7.41%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PHAT) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Phathom Pharmaceuticals, Inc. to open at $10.04, and during the day (based on 14 day Average True Range), to move between $9.76 and $10.50, which gives a possible trading interval of +/-$0.737 (+/-7.54%) up or down from last closing price. If Phathom Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.09 (0.39%) than the resistance at $11.20 (10.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Phathom Pharmaceuticals, Inc. stock A Buy?

Phathom Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.145 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $10.04 ( 0.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk